New brain valve registry aims to confirm safety for fluid buildup
NCT ID NCT05397106
First seen Jan 14, 2026 · Last updated Jun 22, 2026 · Updated 29 times
Summary
This study is tracking 160 patients who have or will receive the CODMAN CERTAS Plus programmable valve, a device implanted in the brain to drain excess fluid. The goal is to see if the valve is placed correctly and works well 30 days after surgery. Participants include people with hydrocephalus, normal pressure hydrocephalus, brain tumors, or related conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AZ Delta - Roeselare
Roeselare, Belgium
-
Canton Hospital St. Gallen
Sankt Gallen, Switzerland
-
Freiburg University Hospital
Freiburg im Breisgau, Germany
-
Heinrich Heine University, Dept of Neurosurgery, Universitätsklinik Düsseldorf
Düsseldorf, 40225, Germany
-
Hospital12 de Octubre
Madrid, Spain
-
Katharinenhospital - Neurochirurgische Klinik Stuttgart
Stuttgart, Germany
-
Klinikum Dortmund Wirbelsäulenchirurgie
Dortmund, Germany
-
University Hospital Leuven
Leuven, Belgium
-
Universitätsklinikum Essen
Essen, Germany
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CODMAN CERTAS Plus Programmable Valve (a surgically implanted device that helps drain excess fluid from the brain)
What this could lead to
If successful, this study could confirm that the valve is safe and works as intended for managing hydrocephalus and related conditions.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove the valve is better than other treatments. Results may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.